STOCK TITAN

Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Orthofix Medical Inc. (NASDAQ:OFIX) has scheduled the release of its first quarter 2024 financial results on May 7, 2024, before market open. The company will host a conference call and webcast to review the results at 8:30 a.m. ET on the same day. Interested parties can access the conference call by dialing (888) 330-2508 in the U.S. and (240) 789-2735 in other locations, using event passcode 9556380. A replay will be available for three weeks. A webcast and release copy can be found at ir.Orthofix.com.
Orthofix Medical Inc. (NASDAQ:OFIX) ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2024 per il 7 maggio 2024, prima dell'apertura del mercato. La compagnia terrà una teleconferenza e un webcast per discutere i risultati alle 8:30 del mattino, ora dell'Est, lo stesso giorno. Gli interessati possono partecipare alla teleconferenza componendo il numero (888) 330-2508 negli Stati Uniti e il (240) 789-2735 in altre località, utilizzando il codice di evento 9556380. Sarà disponibile una registrazione dell'evento per tre settimane. Il webcast e la copia del comunicato possono essere trovati su ir.Orthofix.com.
Orthofix Medical Inc. (NASDAQ:OFIX) ha programado el lanzamiento de sus resultados financieros del primer trimestre de 2024 para el 7 de mayo de 2024, antes de la apertura del mercado. La compañía llevará a cabo una conferencia por teléfono y una transmisión en línea para revisar los resultados a las 8:30 a.m. ET el mismo día. Las partes interesadas pueden acceder a la llamada marcando (888) 330-2508 en los EE.UU. y (240) 789-2735 en otras ubicaciones, usando el código de evento 9556380. Una repetición estará disponible durante tres semanas. Se puede encontrar una transmisión en línea y copia del comunicado en ir.Orthofix.com.
Orthofix Medical Inc. (NASDAQ:OFIX)는 2024년 첫 분기 재무 결과를 2024년 5월 7일 시장 개장 전에 발표할 예정입니다. 회사는 같은 날 동부 표준시로 오전 8시 30분에 결과를 검토하기 위한 전화 회의 및 웹캐스트를 주최할 것입니다. 관심 있는 당사자들은 미국 내에서 (888) 330-2508, 기타 지역에서는 (240) 789-2735번으로 전화하여 이벤트 코드 9556380을 사용하여 회의에 접속할 수 있습니다. 3주간 재생이 가능할 예정입니다. 웹캐스트 및 발표문은 ir.Orthofix.com에서 확인할 수 있습니다.
Orthofix Medical Inc. (NASDAQ:OFIX) a prévu de publier les résultats financiers de son premier trimestre 2024 le 7 mai 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique et un webcast pour examiner les résultats à 8h30 HE le même jour. Les parties intéressées peuvent accéder à la conférence en composant le (888) 330-2508 aux États-Unis et le (240) 789-2735 dans d'autres lieux, en utilisant le code d'événement 9556380. Une rediffusion sera disponible pendant trois semaines. Un webcast et une copie de la publication peuvent être trouvés sur ir.Orthofix.com.
Orthofix Medical Inc. (NASDAQ:OFIX) hat die Veröffentlichung seiner Finanzergebnisse für das erste Quartal 2024 für den 7. Mai 2024, vor Markteröffnung, geplant. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und ein Webcast zur Besprechung der Ergebnisse veranstalten. Interessierte Parteien können über die Telefonnummer (888) 330-2508 in den USA und (240) 789-2735 an anderen Standorten teilnehmen, wobei der Veranstaltungscode 9556380 verwendet wird. Eine Wiederholung wird drei Wochen lang verfügbar sein. Ein Webcast und eine Kopie der Mitteilung finden Sie unter ir.Orthofix.com.
Positive
  • None.
Negative
  • None.

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2024 financial results on Tuesday, May 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 a.m. ET the same day.

Interested parties may access the conference call by dialing (888) 330-2508 in the U.S., and (240) 789-2735 in all other locations, and referencing the event passcode 9556380. A replay of the call will be available for three weeks by dialing (800) 770-2030 in the U.S., and (647) 362-9199 in all other locations, and entering the event passcode 9556380. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.

About Orthofix

Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in more than 60 countries worldwide.

The Company is headquartered in Lewisville, Texas, where it conducts general business, product development, medical education and manufacturing, and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined Company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil.

Investor Relations

Louisa Smith, Gilmartin Group

ir@orthofix.com

Source: Orthofix Medical Inc.

FAQ

When will Orthofix release its first quarter 2024 financial results?

Orthofix will release its first quarter 2024 financial results on May 7, 2024, before market open.

What time will the conference call to review the results take place?

The conference call to review the results will take place at 8:30 a.m. ET on May 7, 2024.

How can interested parties access the conference call?

Interested parties can access the conference call by dialing (888) 330-2508 in the U.S. and (240) 789-2735 in other locations, using event passcode 9556380.

How long will the replay of the conference call be available?

The replay of the conference call will be available for three weeks.

Where can the webcast of the conference call and release copy be accessed?

The webcast of the conference call and release copy can be accessed at ir.Orthofix.com.

Orthofix Medical Inc.

NASDAQ:OFIX

OFIX Rankings

OFIX Latest News

OFIX Stock Data

521.27M
26.16M
3.45%
97.5%
10.25%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
LEWISVILLE

About OFIX

orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing